Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of aprepitant and dexamethasone interaction in adults receiving chemotherapy
NL-OMON52052Completed
- Sponsor
- Netherlands Cancer Institute
- Start
- Jun 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of aprepitant and dexamethasone in chemotherapy-induced nausea and vomiting (CINV) (2 arms), sponsored by Netherlands Cancer Institute. Primary endpoint: Primary pharmacokinetic endpoint. Started Jun 2021; status: completed.
02
Drugs
aprepitantdexamethasone
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NL-OMON52052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52052.